FDAnews Drug Daily Bulletin

Impax Challenges Abbott’s Patents in Connection to Tricor

Nov. 2, 2009
A A
Impax Laboratories, Inc. has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR (fenofibrate) tablets, 48 mg and 145 mg.
StreetInsider